BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 31269506)

  • 1. Clinical Efficacy and Biological Regulations of ω-3 PUFA-Derived Endocannabinoids in Major Depressive Disorder.
    Yang B; Lin L; Bazinet RP; Chien YC; Chang JP; Satyanarayanan SK; Su H; Su KP
    Psychother Psychosom; 2019; 88(4):215-224. PubMed ID: 31269506
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Eicosapentaenoic and docosahexaenoic acids have different effects on peripheral phospholipase A2 gene expressions in acute depressed patients.
    Su KP; Yang HT; Chang JP; Shih YH; Guu TW; Kumaran SS; Gałecki P; Walczewska A; Pariante CM
    Prog Neuropsychopharmacol Biol Psychiatry; 2018 Jan; 80(Pt C):227-233. PubMed ID: 28648567
    [TBL] [Abstract][Full Text] [Related]  

  • 3. EPA but not DHA appears to be responsible for the efficacy of omega-3 long chain polyunsaturated fatty acid supplementation in depression: evidence from a meta-analysis of randomized controlled trials.
    Martins JG
    J Am Coll Nutr; 2009 Oct; 28(5):525-42. PubMed ID: 20439549
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Disentangling the Molecular Mechanisms of the Antidepressant Activity of Omega-3 Polyunsaturated Fatty Acid: A Comprehensive Review of the Literature.
    Kalkman HO; Hersberger M; Walitza S; Berger GE
    Int J Mol Sci; 2021 Apr; 22(9):. PubMed ID: 33922396
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Omega-3 polyunsaturated fatty acids (n-3 PUFAs), somatic and fatigue symptoms in cardiovascular diseases comorbid major depressive disorder (MDD): A randomized controlled trial.
    Chang JP; Chang SS; Chen HT; Chien YC; Yang HT; Huang SY; Tseng PT; Chang CH; Galecki P; Su KP
    Brain Behav Immun; 2023 Aug; 112():125-131. PubMed ID: 37301235
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Similar eicosapentaenoic acid and docosahexaenoic acid plasma levels achieved with fish oil or krill oil in a randomized double-blind four-week bioavailability study.
    Yurko-Mauro K; Kralovec J; Bailey-Hall E; Smeberg V; Stark JG; Salem N
    Lipids Health Dis; 2015 Sep; 14():99. PubMed ID: 26328782
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Baseline blood levels of omega-3 and depression remission: a secondary analysis of data from a placebo-controlled trial of omega-3 supplements.
    Carney RM; Steinmeyer BC; Freedland KE; Rubin EH; Rich MW; Harris WS
    J Clin Psychiatry; 2016 Feb; 77(2):e138-43. PubMed ID: 26930527
    [TBL] [Abstract][Full Text] [Related]  

  • 8. International Society for Nutritional Psychiatry Research Practice Guidelines for Omega-3 Fatty Acids in the Treatment of Major Depressive Disorder.
    Guu TW; Mischoulon D; Sarris J; Hibbeln J; McNamara RK; Hamazaki K; Freeman MP; Maes M; Matsuoka YJ; Belmaker RH; Jacka F; Pariante C; Berk M; Marx W; Su KP
    Psychother Psychosom; 2019; 88(5):263-273. PubMed ID: 31480057
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dysregulation of endocannabinoid concentrations in human subcutaneous adipose tissue in obesity and modulation by omega-3 polyunsaturated fatty acids.
    Fisk HL; Childs CE; Miles EA; Ayres R; Noakes PS; Paras-Chavez C; Kuda O; Kopecký J; Antoun E; Lillycrop KA; Calder PC
    Clin Sci (Lond); 2021 Jan; 135(1):185-200. PubMed ID: 33393630
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Omega-3 fatty acids in the prevention of interferon-alpha-induced depression: results from a randomized, controlled trial.
    Su KP; Lai HC; Yang HT; Su WP; Peng CY; Chang JP; Chang HC; Pariante CM
    Biol Psychiatry; 2014 Oct; 76(7):559-66. PubMed ID: 24602409
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Omega-3 polyunsaturated fatty acids in cardiovascular diseases comorbid major depressive disorder - Results from a randomized controlled trial.
    Chang JP; Chang SS; Yang HT; Chen HT; Chien YC; Yang B; Su H; Su KP
    Brain Behav Immun; 2020 Mar; 85():14-20. PubMed ID: 30902738
    [TBL] [Abstract][Full Text] [Related]  

  • 12. No effect of n-3 long-chain polyunsaturated fatty acid (EPA and DHA) supplementation on depressed mood and cognitive function: a randomised controlled trial.
    Rogers PJ; Appleton KM; Kessler D; Peters TJ; Gunnell D; Hayward RC; Heatherley SV; Christian LM; McNaughton SA; Ness AR
    Br J Nutr; 2008 Feb; 99(2):421-31. PubMed ID: 17956647
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Eicosapentaenoic Acid Versus Docosahexaenoic Acid as Options for Vascular Risk Prevention: A Fish Story.
    Singh S; Arora RR; Singh M; Khosla S
    Am J Ther; 2016; 23(3):e905-10. PubMed ID: 25828517
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dietary linoleic acid lowering alone does not lower arachidonic acid or endocannabinoids among women with overweight and obesity: A randomized, controlled trial.
    Courville AB; Majchrzak-Hong S; Yang S; Turner S; Wilhite B; Ness Shipley K; Horneffer Y; Domenichiello AF; Schwandt M; Cutler RG; Chen KY; Hibbeln JR; Ramsden CE
    Lipids; 2023 Nov; 58(6):271-284. PubMed ID: 38100748
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Omega-3 polyunsaturated fatty acid (PUFA) status in major depressive disorder with comorbid anxiety disorders.
    Liu JJ; Galfalvy HC; Cooper TB; Oquendo MA; Grunebaum MF; Mann JJ; Sublette ME
    J Clin Psychiatry; 2013 Jul; 74(7):732-8. PubMed ID: 23945451
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preoperative oral supplementation with long-chain Omega-3 fatty acids beneficially alters phospholipid fatty acid patterns in liver, gut mucosa, and tumor tissue.
    Senkal M; Haaker R; Linseisen J; Wolfram G; Homann HH; Stehle P
    JPEN J Parenter Enteral Nutr; 2005; 29(4):236-40. PubMed ID: 15961678
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lipid correlates of antidepressant response to omega-3 polyunsaturated fatty acid supplementation: A pilot study.
    Ganança L; Galfalvy HC; Oquendo MA; Hezghia A; Cooper TB; Mann JJ; Sublette ME
    Prostaglandins Leukot Essent Fatty Acids; 2017 Apr; 119():38-44. PubMed ID: 28410668
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Omega-3 and Omega-6 Polyunsaturated Fatty Acid Levels and Correlations with Symptoms in Children with Attention Deficit Hyperactivity Disorder, Autistic Spectrum Disorder and Typically Developing Controls.
    Parletta N; Niyonsenga T; Duff J
    PLoS One; 2016; 11(5):e0156432. PubMed ID: 27232999
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of long-chain omega-3 polyunsaturated fatty acids on reducing anxiety and/or depression in adults; A systematic review and meta-analysis of randomised controlled trials.
    Kelaiditis CF; Gibson EL; Dyall SC
    Prostaglandins Leukot Essent Fatty Acids; 2023 May; 192():102572. PubMed ID: 37028202
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Meta-analysis and meta-regression of omega-3 polyunsaturated fatty acid supplementation for major depressive disorder.
    Mocking RJ; Harmsen I; Assies J; Koeter MW; Ruhé HG; Schene AH
    Transl Psychiatry; 2016 Mar; 6(3):e756. PubMed ID: 26978738
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.